arrow_back Back to App

No Tax Breaks for Prescription Drug Ads

This bill aims to prevent pharmaceutical companies from deducting the cost of prescription drug advertisements from their taxes. This means that drug ads seen on TV, online, or in newspapers will no longer reduce their tax obligations. This could impact the volume and type of drug advertisements citizens encounter.
Key points
Pharmaceutical companies will no longer be able to deduct the cost of prescription drug advertising from their taxes.
This change applies to direct-to-consumer advertising, including TV, radio, internet, newspapers, and billboards.
The goal is to potentially reduce the number of drug advertisements, which may affect consumer awareness of available medications.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_6392
Sponsor: Rep. Slotkin, Elissa [D-MI-8]
Process start date: 2022-01-13
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

No Tax Breaks for Drug Ads Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_6392.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-01-13.

What are the main provisions?

Key points include:

  • Pharmaceutical companies will no longer be able to deduct the cost of prescription drug advertising from their taxes.
  • This change applies to direct-to-consumer advertising, including TV, radio, internet, newspapers, and billboards.
  • The goal is to potentially reduce the number of drug advertisements, which may affect consumer awareness of available medications.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Slotkin, Elissa [D-MI-8].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Ways and Means.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Taxes Health